72 results
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
9 Feb 24
InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer
12:34pm
not directly or indirectly solicit or entice any person who is an employee or contractor of the Company to leave employment or engagement with the Company
8-K
EX-99.1
INM
InMed Pharmaceuticals Inc
19 Jan 24
Regulation FD Disclosure
2:33pm
, visit www.inmedpharma.com.
About Water Tower Research:
Water Tower Research is a shareholder communication and engagement platform powered by senior … to strengthen overall communications, transparency, and engagement. For more information, visit https://www.watertowerresearch.com/home.
Investor Contact:
Colin
8-K
EX-4.3
INM
InMed Pharmaceuticals Inc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
in Section 2(b). This Preferred Investment Option is being issued pursuant to that certain engagement letter, dated as of October 24, 2023
8-K
INM
InMed Pharmaceuticals Inc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
as the exclusive placement agent for the Offerings.
Engagement Letter
The Company entered into an engagement letter with Wainwright, dated October 24 … , 2023 (the “Engagement Letter”), pursuant to which Wainwright agreed to serve as the Company’s exclusive agent, advisor or underwriter in certain
8-K
EX-99.1
4xd 0oq8g9pwd05
24 Jul 23
Regulation FD Disclosure
4:26pm
8-K
EX-99.1
eqbux8 4b2tnp0pn
19 May 23
Regulation FD Disclosure
1:41pm
8-K
EX-99.1
v958lpdm8qob1qu19cm
13 Dec 22
InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor
4:01pm
8-K
EX-99.1
gbk4kb2
13 Dec 22
InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor
3:47pm
8-K
EX-10.1
poq kng42ttbarw1
13 Dec 22
InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor
3:47pm
8-K
EX-10.2
kvht3h8
13 Dec 22
InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor
3:47pm
8-K
kaejtsat
12 Dec 22
Changes in Registrant's Certifying Accountant
8:14pm
8-K
r65croa1ce4guxji8n
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
8-K
EX-4.3
btm xet3f6
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
8-K
EX-99.1
gcnl4mvp4m7
17 Nov 22
Departure of Directors or Certain Officers
4:10pm
8-K
3bptksol70k26
17 Nov 22
Departure of Directors or Certain Officers
4:10pm